CME-certified Webcast of a CCO symposium at ASH 2019 featuring expert perspectives on the treatment of β-thalassemia, including insights on novel therapies.
CCO faculty Maria Domenica Capellini, MD, provides insights on the use of luspatercept in the care of adult patients with transfusion-dependent β-thalassemia
Analysis of responders from BELIEVE study of luspatercept for transfusion-dependent β-thalassemia from ASH 2019 as reported by Clinical Care Options (CCO)
Data from phase III CARDINAL trial of sutimlimab in patients with cold agglutinin disease presented at ASH 2019 reported by Clinical Care Options
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.